Correlation Between Genmab AS and FLSmidth

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and FLSmidth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and FLSmidth into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and FLSmidth Co, you can compare the effects of market volatilities on Genmab AS and FLSmidth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of FLSmidth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and FLSmidth.

Diversification Opportunities for Genmab AS and FLSmidth

-0.85
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Genmab and FLSmidth is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and FLSmidth Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FLSmidth and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with FLSmidth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FLSmidth has no effect on the direction of Genmab AS i.e., Genmab AS and FLSmidth go up and down completely randomly.

Pair Corralation between Genmab AS and FLSmidth

Assuming the 90 days trading horizon Genmab AS is expected to under-perform the FLSmidth. In addition to that, Genmab AS is 1.37 times more volatile than FLSmidth Co. It trades about 0.0 of its total potential returns per unit of risk. FLSmidth Co is currently generating about 0.25 per unit of volatility. If you would invest  35,740  in FLSmidth Co on September 1, 2024 and sell it today you would earn a total of  2,780  from holding FLSmidth Co or generate 7.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  FLSmidth Co

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
FLSmidth 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in FLSmidth Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, FLSmidth may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Genmab AS and FLSmidth Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and FLSmidth

The main advantage of trading using opposite Genmab AS and FLSmidth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, FLSmidth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FLSmidth will offset losses from the drop in FLSmidth's long position.
The idea behind Genmab AS and FLSmidth Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Global Correlations
Find global opportunities by holding instruments from different markets